Ellagic acid inhibits human colon cancer HCT-116 cells by regulating long noncoding RNAs
- PMID: 36847079
- PMCID: PMC10569677
- DOI: 10.1097/CAD.0000000000001513
Ellagic acid inhibits human colon cancer HCT-116 cells by regulating long noncoding RNAs
Abstract
The natural phenolic compound ellagic acid exerts anti-cancer effects, including activity against colorectal cancer (CRC). Previously, we reported that ellagic acid can inhibit the proliferation of CRC, and can induce cell cycle arrest and apoptosis. This study investigated ellagic acid-mediated anticancer effects using the human colon cancer HCT-116 cell line. After 72 h of ellagic acid treatment, a total of 206 long noncoding RNAs (lncRNAs) with differential expression greater than 1.5-fold were identified (115 down-regulated and 91 up-regulated). Furthermore, the co-expression network analysis of differentially expressed lncRNA and mRNA showed that differential expressed lncRNA might be the target of ellagic acid activity in inhibiting CRC.
Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
There are no conflicts of interest.
Figures




Similar articles
-
Long noncoding RNA kcna3 inhibits the progression of colorectal carcinoma through down-regulating YAP1 expression.Biomed Pharmacother. 2018 Nov;107:382-389. doi: 10.1016/j.biopha.2018.07.118. Epub 2018 Aug 9. Biomed Pharmacother. 2018. PMID: 30099342
-
Genome-wide analysis of long noncoding RNA (lncRNA) expression in colorectal cancer tissues from patients with liver metastasis.Cancer Med. 2016 Jul;5(7):1629-39. doi: 10.1002/cam4.738. Epub 2016 May 11. Cancer Med. 2016. PMID: 27165481 Free PMC article.
-
Linc00659, a long noncoding RNA, acts as novel oncogene in regulating cancer cell growth in colorectal cancer.Mol Cancer. 2018 Mar 10;17(1):72. doi: 10.1186/s12943-018-0821-1. Mol Cancer. 2018. PMID: 29523145 Free PMC article.
-
Identification of MFI2-AS1, a Novel Pivotal lncRNA for Prognosis of Stage III/IV Colorectal Cancer.Dig Dis Sci. 2020 Dec;65(12):3538-3550. doi: 10.1007/s10620-020-06064-1. Epub 2020 Jan 20. Dig Dis Sci. 2020. PMID: 31960204 Review.
-
Mechanisms of long non-coding RNA function in colorectal cancer tumorigenesis.Asia Pac J Clin Oncol. 2021 Feb;17(1):7-23. doi: 10.1111/ajco.13452. Epub 2020 Sep 24. Asia Pac J Clin Oncol. 2021. PMID: 32970938 Review.
Cited by
-
Berries vs. Disease: Revenge of the Phytochemicals.Pharmaceuticals (Basel). 2024 Jan 9;17(1):84. doi: 10.3390/ph17010084. Pharmaceuticals (Basel). 2024. PMID: 38256917 Free PMC article. Review.
References
-
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68:394–424. - PubMed
-
- Chen D, Song S, Lu J, Luo Y, Yang Z, Huang Q, et al. . Functional variants of -1318T>G and -673C>T in c-Jun promoter region associated with increased colorectal cancer risk by elevating promoter activity. Carcinogenesis 2011; 32:1043–1049. - PubMed
-
- Yang G, Lu X, Yuan L. ncRNA: a link between RNA and cancer. Biochim Biophys Acta 2014; 1839:1097–1109. - PubMed
-
- Huarte M. The emerging role of lncRNA in cancer. Nat Med 2015; 21:1253–1261. - PubMed
LinkOut - more resources
Full Text Sources